Galectin Therapeutics

Peter G. Traber, M.D.,
President, Chief Executive Officer and Chief Medical Officer
Harold H. Shlevin, PhD,
Chief Operating Officer and Corporate Secretary
Eliezer Zomer, Ph.D.,
Executive Vice President, Manufacturing and Product Development
Thomas A. McGauley, CPA,
Acting Chief Financial Officer
Rex Norton,
Executive Director of Regulatory Affairs and Quality Assurance

James C. Czirr,
Executive Chairman of the Board
Gilbert F. Amelio, Ph.D.,
Kevin D. Freeman, CFA,
Arthur R. Greenberg,
Rod D. Martin,
John Mauldin,
Steven Prelack,
Paul Pressler,
Jerald K. Rome,
Marc Rubin, M.D.,
Peter G. Traber, M.D.